Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Pinterest: User Growth and Monetization
Here's our initial take on Pinterest's (NYSE: PINS) financial report.Key MetricsMetricQ4 2023Q4 2024Changevs. ExpectationsRevenue$981.3 million$1.154 billion18%BeatEarnings per share (adjusted)$0.53$0.566%MissedMonthly active users (MAU)498 million553 million11%BeatAverage revenue per user (ARPU)$2....
The Motley Fool
Feb 7, 2025
e.l.f. Cuts Fiscal 2025 Outlook
Here's our initial take on e.l.f. Beauty's (NYSE: ELF) fiscal third-quarter financial report.Key MetricsMetricQ3 FY 2024Q3 FY 2025Changevs. ExpectationsTotal revenue$270.9 million$355.3 million 31%BeatAdjusted earnings per share$0.74$0.740%MissedGross margin70.85%71.29% 0.44 ppn/aAdjusted EBITDA$59....
The Motley Fool
Feb 7, 2025
Best Stock to Buy Right Now: Coca-Cola vs. Kraft Heinz
Everyone loves a bargain, especially on Wall Street. But just because a company's stock is cheap doesn't mean it is worth owning.This is what you need to keep in the back of your mind as you compare Kraft Heinz (NASDAQ: KHC) to Coca-Cola (NYSE: KO). Both companies have seen stock declines over the p...
The Motley Fool
Feb 7, 2025
BUZZ-Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO
** Shares of drug developer Sionna Therapeutics SION.O set to open 33% above their offer price in their Nasdaq debut ** Stock indicated to open at $24 vs $18 IPO price ** SION sold ~10.6 mln shares, 20% more than initially offered, at the top end of its marketed range of $16 to $18 apiec...
Reuters
Feb 7, 2025
South African rand gains as president promises reforms
Updates prices as of 1531 GMT; adds analyst comment in paragraph 4 JOHANNESBURG, Feb 7 (Reuters) - South Africa's rand firmed on Friday after President Cyril Ramaphosa said his government would launch a second wave of reforms to try to boost economic growth. At 1531 GMT, the rand traded at 18...
Reuters
Feb 7, 2025
Gerresheimer: in early talks with private-equity suitors
Updates with company confirmation Feb 7 (Reuters) - German medical packaging maker Gerresheimer GXIG.DE on Friday said it was in early-stage discussions with private equity investors over a potential sale of the company, adding that it would evaluate any offers in the best interest of the company...
Reuters
Feb 7, 2025
BUZZ-Genpact surges to record high after results, outlook
** Genpact G.N up 11.6% to $55.13 after hitting record high of $56.76 and on track for biggest daily pct gain since Aug 9** The professional services company reported Q4 adj EPS and revenue that topped Street estimates after the close on Thursday while also giving its Q1 and FY 2025 outlook ** BMO r...
Reuters
Feb 7, 2025
LIVE MARKETS-Wall Street eases early with Amazon
Main US indexes modestly red; Nasdaq off most, down ~0.6%Feb UMich prelim sentiment 67.8 vs 71.1 estimateEuro STOXX 600 index off ~0.3%Dollar edges up; gold, crude both gain ~1%; bitcoin up ~2%U.S. 10-Year Treasury yield rises to ~4.50%Welcome to the home for real-time coverage of markets brought to...
Reuters
Feb 7, 2025
Wall St Week Ahead-Inflation data to test market as tariff talk swirls
Adds details on jobs data in paragraph 12, Fed chair set to testify in paragraph 17By Lewis Krauskopf, Saqib Iqbal Ahmed NEW YORK, Feb 7 (Reuters) - A fresh look at the pace of inflation will test the U.S. stock market in the coming week, as investors worry that President Donald Trump's tarif...
Reuters
Feb 7, 2025
Air Products and Chemicals downgraded by JP Morgan, BMO Capital
Investing.com -- Analysts at JP Morgan and BMO Capital Markets downgraded Air Products and Chemicals Inc (NYSE:APD) on concerns over earnings growth, currency headwinds, and management transition.JP M
Investing.com
Feb 7, 2025
US STOCKS-Wall St falls on expectations of Fed caution after jobs data
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.Nonfarm payrolls increase by 143,000 in January Microchip falls on downbeat Q4 net sales, profit forecastIndexes down: Dow 0.16%, S&P 500 0.19%, Nasdaq 0.55%Updates after markets openBy Sha...
Reuters
Feb 7, 2025
BUZZ-Xcel Energy rises after brokerages raise PT
** Shares of Xcel Energy XEL.O rise ~1% to $67.71** Brokerage BMO Capital Markets raises PT to $69 from $67, maintains "market perform" rating** XEL on Thursday missed Q2 profit estimates but reaffirmed 2025 profit forecast range of $3.75 to 3.85 per share** BMO says the earnings trajectory ...
Reuters
Feb 7, 2025
BUZZ-Byrna Technologies rises after swinging to profit in Q4
** Shares of self-defense equipment maker Byrna Technologies BYRN.O up 5% at $28.90** BYRN records profit of 43 cents per share vs loss of 4 cents per share a year earlier** Co posts quarterly net revenue of $28 mln as compared with $15.6 mln in the prior year** Signed LOI to launch a pilot store-wi...
Reuters
Feb 7, 2025
BUZZ-Freight Tech rises on plan to lay off 20% of employees
** Shares of supply chain manager Freight Technologies FRGT.O rise 5.5% to $1.25** FRGT to lay off about 20% if its employees to reduce operating costs, co says** As of Dec. 31, 2023, FRGT had 78 full-time employees, according to SEC filling** Co says it is also launching its transportation manageme...
Reuters
Feb 7, 2025
Electric-truck maker Nikola nears bankruptcy filing, WSJ reports (February 6)
Corrects last paragraph of February 6 story to clarify that Nikola has done just one reverse stock split, not multiple; the error was also present in previous versions of the storyFeb 6 (Reuters) - Electric-truck maker Nikola NKLA.O is nearing filing for a bankruptcy, the Wall Street Journal reporte...
Reuters
Feb 7, 2025
BUZZ-Neurocrine falls after analysts say forecast for key drug 'conservative'
** Shares of drugmaker Neurocrine Biosciences NBIX.O decline about 15% to $128.54 ** Co forecasts sales of its drug Ingrezza in the range of $2.5 bln to $2.6 bln for 2025, in line with analysts' expectations of $2.55 bln - according to LSEG data ** Ingrezza is approved for treating invol...
Reuters
Feb 7, 2025
1 Top Vanguard Fund That Could Be the Best Value Investment Right Now
Did you know that in the past five years, the S&P 500's total return (which includes dividends) is around 100%? That's even including a disastrous year for the markets in 2022 when many stocks incurred significant declines. The S&P 500's long-run average is approximately 10% but over the past five y...
The Motley Fool
Feb 7, 2025
Jefferies cuts Sunnova stock rating, slashes target to $2
Investing.com -- Jefferies downgraded Sunnova Energy International Inc (NYSE:NOVA) to "Hold" from "Buy" and cut its price target to $2 from $9 given liquidity concerns and a shift in focus from gr
Investing.com
Feb 7, 2025
BUZZ-Newell Brands slump after Q1 loss forecast
Updates** Shares of Sharpie maker Newell Brands NWL.O plunge 23.7% to $7.41 in early trading** Stock set for its worst day since October 2017, if losses hold** NWL expects Q1 loss on increased promotional costs, and greater-than-expected decline in annual sales due to tepid demand** Sees Q1 loss bet...
Reuters
Feb 7, 2025
BUZZ-Elf Beauty eyes worst day in over 6 years on annual forecast cut
Updates** Shares of makeup company Elf Beauty ELF.N fall as much as 28% to over two-year low of $63.50 ** Stock set for worst day since August 2018 ** Company cuts its annual net sales and profit forecasts, citing weak demand in mass beauty category at the start of the year** Demand was softer i...
Reuters
Feb 7, 2025
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free